Boehringer Ingelheim's new treatment for patients with drug-resistant HIV has been recommended for approval by the European regulator.The prevalence of …
Manufacturers of three Alzheimer's treatments have been asked to supply more information to NICE to help decide whether or not …
A new forum has been launched to promote dialogue between healthcare stakeholders and improve public perception of the pharma industry.The …
A new 28-day pack of Merck Sharp & Dohme's top-selling hypertension treatment Cozaar has been launched in the UK.The 50mg …
GlaxoSmithKline’s Arixtra has gained approval for use in preventing blood clots in high-risk patients undergoing abdominal surgery.The drug is already …
AstraZeneca's oncology compound ZD6474 has entered phase III trials after positive results in trials in non-small cell lung cancer.The drug, …
AstraZeneca is investing in a range of next generation cholesterol drugs which could reverse existing vascular disease in patients.The Anglo-Swedish …
Doctors are a diverse group of people. From GPs to specialists, with the more than 60 areas of medicine that …
The NHS tsar for primary care has called on clinicians to challenge the way they undertake clinical practice in order …
Plans to redesign the primary care landscape with the creation of purpose-built super surgeries are in many cases unfeasible, according …
GlaxoSmithKline has awarded the pan-European launch of a major new neurological product to Euro RSCG Life MSC, following a three-way …
Website links to details of more than 4,000 clinical trials have been published by the ABPI, as the global agreement …
Pfizer has pulled out of an agreement with Altana Pharma to develop and market a new treatment for asthma and …
Pharma economists will tell you that the world has a market 'top three'. The US is way ahead in the …
UK-based pharmaceutical companies have pre-empted strict new European rules on entertaining healthcare professionals by imposing their own restrictions.The companies are …